AIMEE CASAREZ: Open Payments
NPI 1568135432 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 42 payments from 18 companies in 2025. Trend: 2023 $548 · 2024 $4,237 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $218 |
| Merck Sharp & Dohme LLC | 6 | $134 |
| ABBVIE INC. | 4 | $90 |
| Astellas Pharma US Inc | 3 | $69 |
| Genmab U.S., Inc. | 2 | $55 |
| Eisai Inc. | 2 | $49 |
| Tactile Systems Technology Inc | 1 | $38 |
| Sandoz Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Davol Inc. | 1 | $27 |
Products named: LYNPARZA, Enhertu, KEYTRUDA, ELAHERE, Veozah, Tivdak, Lenvima, Flexitouch Plus.
Industry payments across NM — which companies pay providers there.
